Background: Prostate cancer (PCa) represents a common disease in men aged >65 years. The role of physical activity (PA) in patients at risk or diagnosed with PCa represents an evolving issue. We aimed to summarize available evidences about the impact of PA on the pathophysiology and clinical outcomes of PCa. Methods: We performed a narrative review. Evidences about the role of PA in elderly patients in terms of PCa biology, epidemiology, oncological and functional outcomes, as well as in terms of impact on the outcomes of androgen deprivation therapy (ADT) were summarized. Results: Potential pathophysiological pathways hypothesized to explain the benefits of PA in terms of prostate carcinogenesis include circulating levels of Insulin-like growth factor-1 (IGF-1), oxidative stress, systemic inflammation, sex hormones, and myokines. Clinically, emerging evidences support the hypothesis that PA is associated with decreased PCa risk, improved PCa-related survival, improved functional outcomes, and reduced ADT-related adverse events.
Background: Prostate cancer (PCa) represents a common disease in men aged >65 years. The role of physical activity (PA) in patients at risk or diagnosed with PCa represents an evolving issue. We aimed to summarize available evidences about the impact of PA on the pathophysiology and clinical outcomes of PCa. Methods: We performed a narrative review. Evidences about the role of PA in elderly patients in terms of PCa biology, epidemiology, oncological and functional outcomes, as well as in terms of impact on the outcomes of androgen deprivation therapy (ADT) were summarized. Results: Potential pathophysiological pathways hypothesized to explain the benefits of PA in terms of prostate carcinogenesis include circulating levels of Insulin-like growth factor-1 (IGF-1), oxidative stress, systemic inflammation, sex hormones, and myokines. Clinically, emerging evidences support the hypothesis that PA is associated with decreased PCa risk, improved PCa-related survival, improved functional outcomes, and reduced ADT-related adverse events.
Entities:
Keywords:
adjuvant treatment; cancer prevention; elderly; physical activity; prostate cancer
Authors: Giuseppe Celentano; Massimiliano Creta; Luigi Napolitano; Marco Abate; Roberto La Rocca; Marco Capece; Claudia Mirone; Simone Morra; Francesco Di Bello; Luigi Cirillo; Francesco Mangiapia; Gianluigi Califano; Claudia Collà Ruvolo; Caterina Sagnelli; Antonello Sica; Armando Calogero; Fabrizio Iacono; Ferdinando Fusco; Vincenzo Mirone; Nicola Longo Journal: Diagnostics (Basel) Date: 2022-06-15
Authors: Antonello Sica; Beniamino Casale; Caterina Sagnelli; Maria Teresa Di Dato; Pietro Buonavolontà; Anna Maria Salzano; Evangelista Sagnelli; Vincenzo Famiglietti; Elisabetta Saracco; Dario Tammaro; Alfonso Papa Journal: Front Neurol Date: 2020-11-13 Impact factor: 4.003
Authors: Michela Gravina; Lorenzo Spirito; Giuseppe Celentano; Marco Capece; Massimiliano Creta; Gianluigi Califano; Claudia Collà Ruvolo; Simone Morra; Massimo Imbriaco; Francesco Di Bello; Antonio Sciuto; Renato Cuocolo; Luigi Napolitano; Roberto La Rocca; Vincenzo Mirone; Carlo Sansone; Nicola Longo Journal: Diagnostics (Basel) Date: 2022-06-28
Authors: Antonello Sica; Beniamino Casale; Caterina Sagnelli; Maria Teresa Di Dato; Marco Rispoli; Mario Santagata; Pietro Buonavolontà; Alfonso Fiorelli; Paola Vitiello; Stefano Caccavale; Massimiliano Creta; Anna Maria Salzano; Evangelista Sagnelli; Elisabetta Saracco; Giuseppe Gazzerro; Vincenzo Famiglietti; Dario Tammaro; Alfonso Papa Journal: Healthcare (Basel) Date: 2021-05-18
Authors: Antonello Sica; Caterina Sagnelli; Alfonso Papa; Massimo Ciccozzi; Evangelista Sagnelli; Armando Calogero; Erika Martinelli; Beniamino Casale Journal: Int J Environ Res Public Health Date: 2020-03-16 Impact factor: 3.390